Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study.

Sjöberg, Tomas

Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study. [electronic resource] - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Oct 2007 - 1160-1166.e1 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1542-7714

10.1016/j.cgh.2007.08.005 doi


Adenocarcinoma--epidemiology
Adult
Age Factors
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Carcinoma, Squamous Cell--epidemiology
Esophageal Neoplasms--epidemiology
Follow-Up Studies
Humans
Middle Aged
Morbidity--trends
Odds Ratio
Retrospective Studies
Risk Factors
Stomach Neoplasms--epidemiology
United Kingdom--epidemiology